More
    Guided Solutions - Connecting Talent With Innovation/div>

    Arsenal Medical announces first patient treated with ResQFoam

    Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study at the University of Alabama at Birmingham (UAB). Related: TECLens begins...

    Arsenal Medical announces first patient treated with ResQFoam

    Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...

    Airiver Medical wins FDA breakthrough nod for drug-coated balloon

    Airiver Medical announced that it received FDA breakthrough device designation for its pulmonary drug-coated balloon (DCB). Additionally, Airiver announced the first treated patients in a...

    Polares Medical raises $50M for heart leaflet replacement system

    Polares Medical announced that it closed a $50 million Series C financing round to support its heart leaflet replacement system. Lausanne, Switzerland-based Polares designed its...

    Xsensio raises $7M for continuous biosensing tech

    Xsensio announced that it closed a $7 million oversubscribed Series A financing round to support its patient monitoring technology. The Lausanne, Switzerland-based company develops technology...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Arsenal Medical announces first patient treated with ResQFoam

    Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...

    TECLens begins first-in-human trial for qCXL vision correction technology

    TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...

    VESTECK announces the results for SUTURE-TIGHT Endovascular Repair Catheter

    VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...

    Kandu trial highlights positive outcomes with IpsiHand BCI system

    Kandu Health announced positive results from the first randomized controlled trial of its brain-computer interface (BCI) therapy. The trial evaluated its FDA-cleared, non-invasive IpsiHand BCI...

    Innovation

    Regulatory Approvals

    Arsenal Medical announces first patient treated with ResQFoam

    Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...

    Airiver Medical wins FDA breakthrough nod for drug-coated balloon

    Airiver Medical announced that it received FDA breakthrough device designation for its pulmonary drug-coated balloon (DCB). Additionally, Airiver announced the first treated patients in a...

    Polares Medical raises $50M for heart leaflet replacement system

    Polares Medical announced that it closed a $50 million Series C financing round to support its heart leaflet replacement system. Lausanne, Switzerland-based Polares designed its...

    Xsensio raises $7M for continuous biosensing tech

    Xsensio announced that it closed a $7 million oversubscribed Series A financing round to support its patient monitoring technology. The Lausanne, Switzerland-based company develops technology...

    M&A

    Archives

    Latest articles